NASDAQ:CRDF | Free Cash Flow | Cardiff Oncology, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2011-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$12.29M
2025-12-31-$5.97M$0.00-$5.97M
2025-03-31-$12.79M
2024-12-31-$10.27M$0.00-$10.27M
2024-03-31-$7.74M$80,000.00-$7.82M
2023-12-31-$7.14M$8,000.00-$7.15M
2023-03-31-$8.66M$8,000.00-$8.67M
2022-12-31-$9.39M$75,000.00-$9.47M
2022-03-31-$10.25M$171,000.00-$10.42M
2021-12-31-$7.39M$107,000.00-$7.5M
2021-03-31-$5.88M$0.00-$5.88M
2020-12-31-$5.12M$57,000.00-$5.18M
2020-03-31-$3.37M$0.00-$3.37M
2019-12-31-$3.28M$0.00-$3.28M
2019-03-31-$3.36M$5,274.00-$3.37M
2018-12-31-$3.61M$0.00-$3.61M
2018-03-31-$2.86M$5,100.00-$2.86M
2017-12-31-$3.33M-$35,150.00-$3.37M
2017-03-31-$8.76M$11,452.00-$8.77M
2016-12-31-$9M$25,702.00-$9.03M
2016-03-31-$6.92M$352,023.00-$7.27M
2015-12-31-$6.81M$984,078.00-$7.79M
2015-03-31-$4.73M$247,097.00-$4.98M
2014-12-31-$3.87M$127,667.00-$3.99M
2014-03-31-$2.8M$118,507.00-$2.92M
2013-12-31-$1.85M$78,687.00-$1.93M
2013-03-31-$1.63M$93,351.00-$1.72M
2012-12-31-$1.32M$61,860.00-$1.38M
2012-03-31-$905,088.00$98,009.00-$1M
2011-12-31-$520,594.00-$1.00-$520,595.00
2011-03-31-$568,653.00$1,528.00-$570,181.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$37.92M$44,000.00-$37.97M
2024-12-31-$37.69M$80,000.00-$37.77M
2023-12-31-$30.89M$582,000.00-$31.47M
2022-12-31-$33.82M$1.01M-$34.83M
2021-12-31-$23.04M$205,000.00-$23.25M
2020-12-31-$16.32M$211,000.00-$16.53M
2019-12-31-$13.27M$67,622.00-$13.34M
2018-12-31-$13.2M$5,100.00-$13.2M
2017-12-31-$23.28M$101,101.00-$23.38M
2016-12-31-$31.04M$823,483.00-$31.86M
2015-12-31-$22.12M$2.24M-$24.36M
2014-12-31-$12.73M$363,290.00-$13.09M
2013-12-31-$7.32M$649,784.00-$7.97M
2012-12-31-$4.93M$274,080.00-$5.21M
2011-12-31-$1.93M$1,528.00-$1.93M